Views & Analysis A novel approach to detecting Alzheimer’s early The grey matter in the brain may hold vital clues for early, accurate detection in Alzheimer’s, and potentially also help pharma to find new drug treatments.
News Sanofi to buy UK vaccines developer Vicebio for $1.6bn Sanofi has agreed to buy UK startup Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture, for $1.6bn.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face